4//SEC Filing
Wang Xiaolin 4
Accession 0001567619-22-021928
CIK 0001628171other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 4:07 PM ET
Size
5.5 KB
Accession
0001567619-22-021928
Insider Transaction Report
Form 4
Wang Xiaolin
See Remarks
Transactions
- Sale
Common Stock
2022-12-19$22.94/sh−708$16,241→ 30,527 total
Footnotes (3)
- [F1]Pursuant to an automatic sell-to-cover imposed by the terms of the restricted stock units ("RSUs") award, the shares were sold following the vesting of the RSUs solely to cover applicable withholding taxes.
- [F2]This transaction was executed in multiple trades in prices ranging from $22.4706 to $22.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 22,550 RSUs.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001849181
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 4:07 PM ET
- Size
- 5.5 KB